200 related articles for article (PubMed ID: 18836674)
1. The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo.
Still K; Grabowski P; Mackie I; Perry M; Bishop N
Calcif Tissue Int; 2008 Oct; 83(4):285-92. PubMed ID: 18836674
[TBL] [Abstract][Full Text] [Related]
2. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
[TBL] [Abstract][Full Text] [Related]
3. The effect of 3-hydroxybutyrate on the in vitro differentiation of murine osteoblast MC3T3-E1 and in vivo bone formation in ovariectomized rats.
Zhao Y; Zou B; Shi Z; Wu Q; Chen GQ
Biomaterials; 2007 Jul; 28(20):3063-73. PubMed ID: 17418401
[TBL] [Abstract][Full Text] [Related]
4. Galanin treatment offsets the inhibition of bone formation and downregulates the increase in mouse calvarial expression of TNFalpha and GalR2 mRNA induced by chronic daily injections of an injurious vehicle.
McDonald AC; Schuijers JA; Gundlach AL; Grills BL
Bone; 2007 Apr; 40(4):895-903. PubMed ID: 17157570
[TBL] [Abstract][Full Text] [Related]
5. Bezafibrate prevents palmitate-induced apoptosis in osteoblastic MC3T3-E1 cells through the NF-κB signaling pathway.
Zhong X; Xiu L; Wei G; Pan T; Liu Y; Su L; Li Y; Xiao H
Int J Mol Med; 2011 Oct; 28(4):535-42. PubMed ID: 21687928
[TBL] [Abstract][Full Text] [Related]
6. Effect of simulated weightlessness on osteoprogenitor cell number and proliferation in young and adult rats.
Basso N; Bellows CG; Heersche JN
Bone; 2005 Jan; 36(1):173-83. PubMed ID: 15664015
[TBL] [Abstract][Full Text] [Related]
7. Effects of the peroxisome proliferator-activated receptor (PPAR)-δ agonist GW501516 on bone and muscle in ovariectomized rats.
Mosti MP; Stunes AK; Ericsson M; Pullisaar H; Reseland JE; Shabestari M; Eriksen EF; Syversen U
Endocrinology; 2014 Jun; 155(6):2178-89. PubMed ID: 24708238
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis.
Sorocéanu MA; Miao D; Bai XY; Su H; Goltzman D; Karaplis AC
J Endocrinol; 2004 Oct; 183(1):203-16. PubMed ID: 15525588
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of a novel peptide, osteoblast activating peptide (OBAP), associated with osteoblast differentiation and bone formation.
Fukushima N; Hiraoka K; Shirachi I; Kojima M; Nagata K
Biochem Biophys Res Commun; 2010 Sep; 400(1):157-63. PubMed ID: 20709021
[TBL] [Abstract][Full Text] [Related]
10. The effect of reloading on bone volume, osteoblast number, and osteoprogenitor characteristics: studies in hind limb unloaded rats.
Basso N; Jia Y; Bellows CG; Heersche JN
Bone; 2005 Sep; 37(3):370-8. PubMed ID: 16005699
[TBL] [Abstract][Full Text] [Related]
11. Short term effects on bone quality associated with consumption of soy protein isolate and other dietary protein sources in rapidly growing female rats.
Chen JR; Singhal R; Lazarenko OP; Liu X; Hogue WR; Badger TM; Ronis MJ
Exp Biol Med (Maywood); 2008 Nov; 233(11):1348-58. PubMed ID: 18703746
[TBL] [Abstract][Full Text] [Related]
12. Menatetrenone rescues bone loss by improving osteoblast dysfunction in rats immobilized by sciatic neurectomy.
Iwasaki-Ishizuka Y; Yamato H; Murayama H; Ezawa I; Kurokawa K; Fukagawa M
Life Sci; 2005 Feb; 76(15):1721-34. PubMed ID: 15698851
[TBL] [Abstract][Full Text] [Related]
13. PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity.
Patel JJ; Butters OR; Arnett TR
Cell Biochem Funct; 2014 Jun; 32(4):368-77. PubMed ID: 24615887
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-alpha is required for the neurotrophic effect of oleic acid in neurons.
Bento-Abreu A; Tabernero A; Medina JM
J Neurochem; 2007 Nov; 103(3):871-81. PubMed ID: 17683485
[TBL] [Abstract][Full Text] [Related]
15. Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats.
Gilmour PS; O'Shea PJ; Fagura M; Pilling JE; Sanganee H; Wada H; Courtney PF; Kavanagh S; Hall PA; Escott KJ
Toxicol Appl Pharmacol; 2013 Oct; 272(2):399-407. PubMed ID: 23872097
[TBL] [Abstract][Full Text] [Related]
16. PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes.
Nakamachi T; Nomiyama T; Gizard F; Heywood EB; Jones KL; Zhao Y; Fuentes L; Takebayashi K; Aso Y; Staels B; Inukai T; Bruemmer D
Diabetes; 2007 Jun; 56(6):1662-70. PubMed ID: 17360982
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and identification of [1,2,4]thiadiazole derivatives as a new series of potent and orally active dual agonists of peroxisome proliferator-activated receptors alpha and delta.
Shen L; Zhang Y; Wang A; Sieber-McMaster E; Chen X; Pelton P; Xu JZ; Yang M; Zhu P; Zhou L; Reuman M; Hu Z; Russell R; Gibbs AC; Ross H; Demarest K; Murray WV; Kuo GH
J Med Chem; 2007 Aug; 50(16):3954-63. PubMed ID: 17608467
[TBL] [Abstract][Full Text] [Related]
18. Clodronate stimulates bone formation as well as inhibits bone resorption and increases bone mineral density in rats fed a low-calcium diet.
Horie D; Takahashi M; Aoki K; Ohya K
J Med Dent Sci; 2003 Mar; 50(1):121-32. PubMed ID: 12715928
[TBL] [Abstract][Full Text] [Related]
19. Periostin-like-factor in osteogenesis.
Zhu S; Barbe MF; Liu C; Hadjiargyrou M; Popoff SN; Rani S; Safadi FF; Litvin J
J Cell Physiol; 2009 Mar; 218(3):584-92. PubMed ID: 19006175
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol-lowering effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice.
Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Hara A; Hu R; Li G; Li Y; Nakamura K; Gonzalez FJ; Aoyama T
Biochem Pharmacol; 2008 Jul; 76(1):108-19. PubMed ID: 18486101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
